Structure–Activity Relationship Study of Antimalarial Asparagine-Derived Proteasome Inhibitors
ACS Omega · 04.08.2026 · 11 (30) · 45549-45559
DOI: 10.1021/acsomega.6c06226 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 21.07.2026. Verfasst von Hao Zhang und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave, New York, New York 10065, United States. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health, U.S. Department of Defense.
Abstract (Originalsprache)
Malaria remains a significant global health threat, affecting millions of lives each year. The causative agents, Plasmodium parasites, are highly resilient and have developed resistance to nearly all existing antimalarial drugs. The Plasmodium 20S proteasome core (Pf20S), a central component of the parasite’s proteostasis pathway, has emerged as a promising therapeutic target. Inhibiting Pf20S effectively suppresses parasite growth at multiple stages of the parasite life cycle, synergizes with artemisinin-based therapies, and shows no cross-resistance with other antimalarial drug classes. Previously, we identified a novel class of proteasome inhibitors with potent activity against Pf20S, which we subsequently optimized for improved potency and selectivity over human proteasomes. However, these inhibitors exhibited suboptimal pharmacokinetic properties, potentially attributable to a high number of rotatable bonds and hydrogen bond donors. Here, we describe further optimization of this inhibitor class and provide structural insights into Pf20S-inhibitor interactions. Cryo-EM structural studies reveal a novel binding pose of the inhibitor at the Pf20S β5 active site, explaining the enhanced activity of an N-cap sulfonamide modification compared to an N-cap amide. These findings offer insights into the development of next-generation antimalarial Pf20S-targeting compounds with improved drug-like properties.
Autor:innen und Institutionen
- Department of Microbiology & Immunology, Weill Cornell Medicine, 1300 York Ave, New York, New York 10065, United States.
- Department of Structural Biology, Van Andel Institute, Grand Rapids, Michigan 49503, United States.
- Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, 1300 York Ave, New York, New York 10065, United States.
- Sanders Tri-Institutional Therapeutics Discovery Institute, 1230 York Ave., New York, New York 10065, United States.
- Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
- Department of Medicine, University of California, San Francisco, California 94143, United States.
ORCID-Profile: Hao Zhang, Kenjiro Sato, Mayako Michino, Peter T Meinke, Huilin Li, Gang Lin
Förderung
- NIAID NIH HHS
- National Institutes of Health
- U.S. Department of Defense
- Hearst Foundations
- Van Andel Institute
- Memorial Sloan-Kettering Cancer Center
- Takeda Pharmaceutical Company
- Rockefeller University
Zitieren
APA
Zhang, H., Li, D., Hsu, H. C., Vishwanatha, A., Zhan, W., Yukawa, T., Visone, J., Imaeda, T., Okamoto, R., Fajtova, P., Hara, R., Kawasaki, M., Sato, K., Michino, M., Garg, S., Kreutzfeld, O., Tumwebaze, P. K., Orena, S., Okitwi, M., …, & Lin, G. (2026). Structure–Activity Relationship Study of Antimalarial Asparagine-Derived Proteasome Inhibitors. ACS Omega, 11(30), 45549-45559. https://doi.org/10.1021/acsomega.6c06226
Vancouver
Zhang H, Li D, Hsu HC, Vishwanatha A, Zhan W, Yukawa T, et al. Structure–Activity Relationship Study of Antimalarial Asparagine-Derived Proteasome Inhibitors. ACS Omega. 2026;11(30):45549-45559. doi:10.1021/acsomega.6c06226
BibTeX
@article{Zhang2026,
author = {Zhang, Hao and Li, Daqiang and Hsu, Hao-Chi and Vishwanatha, Akshay and Zhan, Wenhu and Yukawa, Takafumi and Visone, Joseph and Imaeda, Toshihiro and Okamoto, Rei and Fajtova, Pavla and Hara, Ryoma and Kawasaki, Masanori and Sato, Kenjiro and Michino, Mayako and Garg, Shreeya and Kreutzfeld, Oriana and Tumwebaze, Patrick K and Orena, Stephen and Okitwi, Martin and Aso, Kazuyoshi and Cooper, Roland A and Rosenthal, Philip J and Meinke, Peter T and Foley, Michael and O'Donoghue, Anthony J and Li, Huilin and Kirkman, Laura A and Lin, Gang},
title = {Structure–Activity Relationship Study of Antimalarial Asparagine-Derived Proteasome Inhibitors},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {30},
pages = {45549--45559},
doi = {10.1021/acsomega.6c06226}
}
EUVIMED